Schizophrenia Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Lundbeck, Intra-cellular Therapies, Sumitomo P…

In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...

Dry Age Macular Degeneration Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Astellas Pharma, Iveric Bio, Apellis Pharma…

Companies across the globe are diligently working toward developing novel Dry Age Macular Degeneration treatment therapies ...
MM&M

Pipeline Report 2025: Late-stage programs set to reshape treatment

As we approach 2026,late-stage programs across key therapeutic areas are poised to reshape treatment paradigms. Driven by novel mechanisms, first-in-class targets and more convenient administration ...
Entrepreneur

Want to Increase Sales? Start With This Weekly Report.

A well-built, regularly reviewed pipeline report isn’t just a sales tool — it’s the crystal ball that shows you where your business is heading, who’s driving growth and how to close the gaps before ...
MarketWatch

Global Oil and Gas Construction Project Insights Report 2025: Pipeline Spending to Average $531 Billion Annually During 2027-2029, Private Financing Dominates With 54.3% Share ...

The "Project Insight - Global Oil and Gas Construction Projects (Q3 2025)" report has been added to ResearchAndMarkets.com's offering. This report provides a detailed analysis of oil and gas projects ...